Evrofarma SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 48.76 million compared to EUR 45.38 million a year ago. Net income was EUR 2.2 million compared to EUR 1.42 million a year ago.

Basic earnings per share from continuing operations was EUR 0.161 compared to EUR 0.1038 a year ago.